Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiayankangtai is a Traditional Chinese Medicine (TCM) herbal formula developed by Dongfang Hospital at the Beijing University of Chinese Medicine for the treatment of Hashimoto's thyroiditis. It is specifically designed to address the TCM syndrome pattern of Liver Depression, Spleen Deficiency, and Blood Stasis. The prescription aims to modulate the autoimmune response and improve thyroid function in patients with chronic lymphocytic thyroiditis. It is currently being evaluated in randomized, double-blind, placebo-controlled clinical trials to assess its efficacy in reducing thyroid autoantibodies and improving clinical symptoms associated with the disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiayankangtai.